The Rise of Precision Medicine
Tuesday, June 5, 2012 at 11:41AM Looks like "precision medicine" has replaced "personalized medicine" as the term of the day to describe therapeutic strategies based on molecular and genomic diagnostics. It's a good description of what we do at GeneKey: using advanced genomic and systems biology methods to understand the biological mechanisms driving an individual patient's cancer, and applying that knowledge to come up with treatment options that target those mechanisms as precisely as the current technology allows. Precision medicine is generating news at the ongoing meeting of the American Society of Clinical Oncology (June 1-5, 2012). OncologySTAT provides an overview of the important trends and discoveries that are being discussed. A free subscription is required to read the full story. Here's are some highlights